Ligand Pharmaceuticals Inc (LGND)
110.04
+4.34
(+4.11%)
USD |
NASDAQ |
Nov 01, 16:00
110.00
-0.04
(-0.04%)
After-Hours: 20:00
Ligand Pharmaceuticals Price to Book Value: 2.593 for Nov. 1, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 01, 2024 | 2.593 |
| October 31, 2024 | 2.491 |
| October 30, 2024 | 2.588 |
| October 29, 2024 | 2.723 |
| October 28, 2024 | 2.672 |
| October 25, 2024 | 2.635 |
| October 24, 2024 | 2.616 |
| October 23, 2024 | 2.519 |
| October 22, 2024 | 2.510 |
| October 21, 2024 | 2.516 |
| October 18, 2024 | 2.507 |
| October 17, 2024 | 2.496 |
| October 16, 2024 | 2.525 |
| October 15, 2024 | 2.460 |
| October 14, 2024 | 2.438 |
| October 11, 2024 | 2.426 |
| October 10, 2024 | 2.364 |
| October 09, 2024 | 2.433 |
| October 08, 2024 | 2.427 |
| October 07, 2024 | 2.418 |
| October 04, 2024 | 2.469 |
| October 03, 2024 | 2.410 |
| October 02, 2024 | 2.356 |
| October 01, 2024 | 2.388 |
| September 30, 2024 | 2.359 |
| Date | Value |
|---|---|
| September 27, 2024 | 2.295 |
| September 26, 2024 | 2.342 |
| September 25, 2024 | 2.328 |
| September 24, 2024 | 2.346 |
| September 23, 2024 | 2.349 |
| September 20, 2024 | 2.423 |
| September 19, 2024 | 2.475 |
| September 18, 2024 | 2.443 |
| September 17, 2024 | 2.457 |
| September 16, 2024 | 2.474 |
| September 13, 2024 | 2.469 |
| September 12, 2024 | 2.406 |
| September 11, 2024 | 2.430 |
| September 10, 2024 | 2.409 |
| September 09, 2024 | 2.422 |
| September 06, 2024 | 2.384 |
| September 05, 2024 | 2.431 |
| September 04, 2024 | 2.417 |
| September 03, 2024 | 2.379 |
| August 30, 2024 | 2.493 |
| August 29, 2024 | 2.495 |
| August 28, 2024 | 2.511 |
| August 27, 2024 | 2.506 |
| August 26, 2024 | 2.479 |
| August 23, 2024 | 2.447 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.8797
Minimum
Mar 16 2020
3.156
Maximum
Feb 09 2021
1.710
Average
1.696
Median
Price to Book Value Benchmarks
| Regeneron Pharmaceuticals Inc | 3.161 |
| Agios Pharmaceuticals Inc | 3.865 |
| ADMA Biologics Inc | 23.98 |
| Pieris Pharmaceuticals Inc | 1.221 |
| AnaptysBio Inc | 60.24 |
Price to Book Value Related Metrics
| PE Ratio | 47.64 |
| PS Ratio | 14.68 |
| PEG Ratio | 0.7885 |
| Price | 110.04 |
| Earnings Yield | 2.10% |
| Market Cap | 2.010B |
| PEGY Ratio | 0.7885 |
| Operating PE Ratio | 245.53 |